FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285185145> ?p ?o ?g. }

• W4285185145 abstract "This study assessed the technical performance of a rapid lateral flow immunochromatographic assay (LFIA) for the detection of anti-SARS-CoV-2 IgG and compared LFIA results with chemiluminescent immunoassay (CLIA) results and an in-house enzyme immunoassay (EIA). To this end, a total of 216 whole blood or serum samples from three groups were analyzed: the first group was composed of 68 true negative cases corresponding to blood bank donors, healthy young volunteers, and eight pediatric patients diagnosed with other coronavirus infections. The serum samples from these participants were obtained and stored in a pre-COVID-19 period, thus they were not expected to have COVID-19. In the second group of true positive cases, we chose to replace natural cases of COVID-19 by 96 participants who were expected to have produced anti-SARS-CoV-2 IgG antibodies 30-60 days after the vaccine booster dose. The serum samples were collected on the same day that LFIA were tested either by EIA or CLIA. The third study group was composed of 52 participants (12 adults and 40 children) who did or did not have anti-SARS-CoV-2 IgG antibodies due to specific clinical scenarios. The 12 adults had been vaccinated more than seven months before LFIA testing, and the 40 children had non-severe COVID-19 diagnosed using RT-PCR during the acute phase of infection. They were referred for outpatient follow-up and during this period the serum samples were collected and tested by CLIA and LFIA. All tests were performed by the same healthcare operator and there was no variation of LFIA results when tests were performed on finger prick whole blood or serum samples, so that results were grouped for analysis. LFIA's sensitivity in detecting anti-SARS-CoV-2 IgG antibodies was 90%, specificity 97.6%, efficiency 93%, PPV 98.3%, NPV 86.6%, and likelihood ratio for a positive or a negative result were 37.5 and 0.01 respectively. There was a good agreement (Kappa index of 0.677) between LFIA results and serological (EIA or CLIA) results. In conclusion, LFIA analyzed in this study showed a good technical performance and agreement with reference serological assays (EIA or CLIA), therefore it can be recommended for use in the outpatient follow-up of non-severe cases of COVID-19 and to assess anti-SARS-CoV-2 IgG antibody production induced by vaccination and the antibodies decrease over time. However, LFIAs should be confirmed by using reference serological assays whenever possible." @default.
• W4285185145 created "2022-07-14" @default.
• W4285185145 creator A5005899265 @default.
• W4285185145 creator A5016131223 @default.
• W4285185145 creator A5018153126 @default.
• W4285185145 creator A5039018247 @default.
• W4285185145 creator A5039518981 @default.
• W4285185145 creator A5050624240 @default.
• W4285185145 creator A5052296309 @default.
• W4285185145 creator A5066066184 @default.
• W4285185145 date "2022-01-01" @default.
• W4285185145 modified "2023-10-18" @default.
• W4285185145 title "Technical performance of a lateral flow immunoassay for detection of anti-SARS-CoV-2 IgG in the outpatient follow-up of non-severe cases and at different times after vaccination: comparison with enzyme and chemiluminescent immunoassays" @default.
• W4285185145 cites W2164777277 @default.
• W4285185145 cites W2557371741 @default.
• W4285185145 cites W3001195213 @default.
• W4285185145 cites W3010604545 @default.
• W4285185145 cites W3012756997 @default.
• W4285185145 cites W3012846954 @default.
• W4285185145 cites W3014067025 @default.
• W4285185145 cites W3014721277 @default.
• W4285185145 cites W3017325113 @default.
• W4285185145 cites W3021039517 @default.
• W4285185145 cites W3021590963 @default.
• W4285185145 cites W3023897783 @default.
• W4285185145 cites W3038559277 @default.
• W4285185145 cites W3043070946 @default.
• W4285185145 cites W3048683141 @default.
• W4285185145 cites W3102976189 @default.
• W4285185145 cites W3104761811 @default.
• W4285185145 cites W3117980245 @default.
• W4285185145 cites W3118944411 @default.
• W4285185145 cites W3119803865 @default.
• W4285185145 cites W3129020586 @default.
• W4285185145 cites W3132324463 @default.
• W4285185145 cites W3135697461 @default.
• W4285185145 cites W3141930699 @default.
• W4285185145 cites W3157571221 @default.
• W4285185145 cites W3157578989 @default.
• W4285185145 cites W3157598477 @default.
• W4285185145 cites W3172713040 @default.
• W4285185145 cites W3177948351 @default.
• W4285185145 cites W3182196820 @default.
• W4285185145 cites W3194867802 @default.
• W4285185145 cites W3212999615 @default.
• W4285185145 cites W4200063940 @default.
• W4285185145 cites W4205829018 @default.
• W4285185145 cites W4205889713 @default.
• W4285185145 cites W4206686602 @default.
• W4285185145 cites W4223986316 @default.
• W4285185145 cites W4225116195 @default.
• W4285185145 cites W4225384126 @default.
• W4285185145 doi "https://doi.org/10.1590/s1678-9946202264049" @default.
• W4285185145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35858039" @default.
• W4285185145 hasPublicationYear "2022" @default.
• W4285185145 type Work @default.
• W4285185145 citedByCount "0" @default.
• W4285185145 crossrefType "journal-article" @default.
• W4285185145 hasAuthorship W4285185145A5005899265 @default.
• W4285185145 hasAuthorship W4285185145A5016131223 @default.
• W4285185145 hasAuthorship W4285185145A5018153126 @default.
• W4285185145 hasAuthorship W4285185145A5039018247 @default.
• W4285185145 hasAuthorship W4285185145A5039518981 @default.
• W4285185145 hasAuthorship W4285185145A5050624240 @default.
• W4285185145 hasAuthorship W4285185145A5052296309 @default.
• W4285185145 hasAuthorship W4285185145A5066066184 @default.
• W4285185145 hasBestOaLocation W42851851452 @default.
• W4285185145 hasConcept C12590561 @default.
• W4285185145 hasConcept C126322002 @default.
• W4285185145 hasConcept C159654299 @default.
• W4285185145 hasConcept C203014093 @default.
• W4285185145 hasConcept C22070199 @default.
• W4285185145 hasConcept C2779134260 @default.
• W4285185145 hasConcept C2780420688 @default.
• W4285185145 hasConcept C3007834351 @default.
• W4285185145 hasConcept C3008058167 @default.
• W4285185145 hasConcept C32611913 @default.
• W4285185145 hasConcept C524204448 @default.
• W4285185145 hasConcept C71924100 @default.
• W4285185145 hasConceptScore W4285185145C12590561 @default.
• W4285185145 hasConceptScore W4285185145C126322002 @default.
• W4285185145 hasConceptScore W4285185145C159654299 @default.
• W4285185145 hasConceptScore W4285185145C203014093 @default.
• W4285185145 hasConceptScore W4285185145C22070199 @default.
• W4285185145 hasConceptScore W4285185145C2779134260 @default.
• W4285185145 hasConceptScore W4285185145C2780420688 @default.
• W4285185145 hasConceptScore W4285185145C3007834351 @default.
• W4285185145 hasConceptScore W4285185145C3008058167 @default.
• W4285185145 hasConceptScore W4285185145C32611913 @default.
• W4285185145 hasConceptScore W4285185145C524204448 @default.
• W4285185145 hasConceptScore W4285185145C71924100 @default.
• W4285185145 hasLocation W42851851451 @default.
• W4285185145 hasLocation W42851851452 @default.
• W4285185145 hasLocation W42851851453 @default.
• W4285185145 hasOpenAccess W4285185145 @default.
• W4285185145 hasPrimaryLocation W42851851451 @default.
• W4285185145 hasRelatedWork W2415633183 @default.
• W4285185145 hasRelatedWork W2810718426 @default.
• W4285185145 hasRelatedWork W3036305013 @default.
• W4285185145 hasRelatedWork W3045746510 @default.

• next